Growth Metrics

Thermo Fisher Scientific (TMO) Income from Continuing Operations (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Income from Continuing Operations readings, the most recent being 1664000000.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations rose 9.11% to 1664000000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 6900000000.0, a 4.61% increase, with the full-year FY2025 number at 6761000000.0, up 5.97% from a year prior.
  • Income from Continuing Operations hit 1664000000.0 in Q1 2026 for Thermo Fisher Scientific, down from 2000000000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 2239000000.0 in Q2 2022 to a low of 1308000000.0 in Q1 2024.
  • Median Income from Continuing Operations over the past 5 years was 1619000000.0 (2025), compared with a mean of 1644117647.06.
  • Biggest five-year swings in Income from Continuing Operations: crashed 41.18% in 2023 and later rose 18.8% in 2024.
  • Thermo Fisher Scientific's Income from Continuing Operations stood at 1604000000.0 in 2022, then rose by 0.19% to 1607000000.0 in 2023, then rose by 11.45% to 1791000000.0 in 2024, then increased by 11.67% to 2000000000.0 in 2025, then fell by 16.8% to 1664000000.0 in 2026.
  • The last three reported values for Income from Continuing Operations were 1664000000.0 (Q1 2026), 2000000000.0 (Q4 2025), and 1619000000.0 (Q3 2025) per Business Quant data.